The analysis identified somatic mutations in APC, KRAS, TP53, and ERBB2 genes in carcinoma, but failed to detect any germline mutations, including in SMAD4, BMPR1A, or PTEN, in hamartomatous polyps and carcinoma. Here, ERBB2 is linked to carcinoma.